Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

MINIject Global Long-Term Follow-up Study

NCT: NCT04524416 · ACTIVE_NOT_RECRUITING

NCT IDNCT04524416
StatusACTIVE_NOT_RECRUITING
Start Date2020-08-05
Completion2026-12
SponsoriSTAR Medical (INDUSTRY)
First posted
Last updated

Brief Summary

The study will assess the long-term (up to 5 years) safety and performance in patients with open-angle glaucoma uncontrolled by topical hypotensive medications who had previously been implanted with a MINIject glaucoma implant.

Frequently Asked Questions

What is MINIject Global Long-Term Follow-up Study?

MINIject Global Long-Term Follow-up Study is a clinical trial registered under NCT04524416. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04524416?

The current status of NCT04524416 (MINIject Global Long-Term Follow-up Study) is: ACTIVE_NOT_RECRUITING.

When did MINIject Global Long-Term Follow-up Study start?

MINIject Global Long-Term Follow-up Study started on 2020-08-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.